AOD-9604 is a modified fragment of the human growth hormone molecule that has drawn research attention in the context of fat-metabolism studies. For laboratories evaluating compounds for experimental work, understanding what AOD-9604 is, how it is characterized, and what the literature has examined is a useful first step. This overview looks at AOD-9604 strictly from a research perspective.
Before going further, an important note: the information here is educational and intended for those handling compounds in a controlled laboratory setting. AOD-9604 discussed here is a research compound. It is not a medicine, supplement, or treatment, and nothing in this article should be interpreted as guidance for human or veterinary use.
What Is AOD-9604?
AOD-9604 is a synthetic peptide derived from the C-terminal region of human growth hormone, corresponding to a fragment often referred to as amino acids 176-191, with a modification at the N-terminus. It was designed to isolate a specific portion of the parent molecule that researchers associated with metabolic activity, without the full sequence of the intact hormone. This makes it a defined, reproducible subject for laboratory study.
Molecular Characteristics
As a short peptide fragment, AOD-9604 has a molecular weight in the low thousands of daltons and a defined amino acid sequence based on the hGH 176-191 region. Its identity is typically confirmed by mass spectrometry and reversed-phase HPLC, which resolve the intended sequence from truncated or modified byproducts that can arise during synthesis.
Mechanisms Studied in Research
In experimental models, AOD-9604 has been examined in relation to lipid metabolism, including pathways associated with the breakdown and utilization of fat in cultured cells and animal studies. Because it derives from a region of growth hormone linked to metabolic signaling, researchers have studied whether the fragment reproduces certain metabolic behaviors without acting through the same broad axis as the intact hormone. These are model-based observations within defined systems, not statements about human outcomes.
Common Research Applications
AOD-9604 appears most often in preclinical metabolic research, particularly studies of adipose tissue biology and lipid handling. It is frequently included alongside other compounds in comparative work; our discussion of the role of peptides in fat metabolism provides broader context for where a fragment like this fits.
Stability and Handling in the Laboratory
Like most research peptides, AOD-9604 is generally handled lyophilized, kept cold, dry, and protected from light, with freeze-thaw cycles minimized after reconstitution. Documenting reconstitution solvent, concentration, and storage temperature supports reproducibility across experiments. Our guide to peptide stability and storage outlines the general principles.
Purity and Quality Considerations
Fragment peptides can carry sequence-related impurities from incomplete synthesis, so purity assessment matters. HPLC purity percentage, mass-spectrometric identity confirmation, and content analysis are standard. Reviewing a certificate of analysis before use lets a laboratory verify identity and purity; our certificate of analysis checklist explains what to look for.
Why Provenance Matters for Reproducible Research
Batch-to-batch differences in synthesis and purification can affect how a fragment behaves in an assay. Traceable provenance and consistent analytical documentation reduce that variability, making provenance part of sound experimental design rather than a formality.
Key Takeaways for Researchers
AOD-9604 is a defined growth-hormone fragment studied primarily in preclinical models of lipid metabolism. Its research value lies in isolating a specific sequence for reproducible study. For laboratory work, identity confirmation, purity verification, and careful storage are the practical priorities, and all use should remain within a controlled research setting.
Frequently Asked Questions
What is AOD-9604 in research? It is a synthetic peptide fragment derived from the C-terminal region of human growth hormone, studied in preclinical models of lipid metabolism. Its uses here are experimental, not established human applications.
How does AOD-9604 relate to growth hormone? It corresponds to a fragment of the hGH molecule (commonly the 176-191 region) with an N-terminal modification, isolating part of the sequence rather than reproducing the intact hormone.
How is AOD-9604 stored in a lab? Typically lyophilized, cold, dry, and protected from light, with freeze-thaw cycles minimized after reconstitution.
How is AOD-9604 purity confirmed? Through HPLC purity analysis and mass spectrometry for identity, supported by content analysis, all documented on a certificate of analysis.
Is AOD-9604 approved for human use? No. As discussed here it is a research compound, not a medicine or supplement, and nothing in this article is guidance for human or veterinary use.
This article is for educational purposes only. AOD-9604 is intended strictly for laboratory and research use and is not for human or veterinary use.
